Please login to the form below

Not currently logged in
Email:
Password:

MINT

This page shows the latest MINT news and features for those working in and with pharma, biotech and healthcare.

Takeda grows in Turkey with Neutec subsidiary acquisition

Takeda grows in Turkey with Neutec subsidiary acquisition

Along with fellow MINT bloc countries Mexico, Indonesia and Nigeria, Turkey is considered an attractive market for the pharma industry thanks to its increasingly affluent population and long-term growth potential,

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • Deep Dive - MINT: opportunities in ‘frontier’ markets?

    Deep Dive - MINT: opportunities in ‘ frontier’ markets? According to British economist Jim O’ Neill, MINT is the new BRIC. ... What is MINT? An acronym he coined for the ‘ frontier’ markets of Mexico, Indonesia, Nigeria and Turkey.

  • Is MINT the next BRIC?

    Is MINT the next BRIC? In 2001, British economist Jim O’ Neill coined the now ubiquitous acronym ‘ BRIC’, to stand for the four emerging economies of Brazil, Russia, India and China, ... We will continue to monitor the MINT market, and aim to

  • Turkey: Identifying the Growth Drivers

    Last year, I concluded my series of articles outlining the challenges and opportunities for pharma in the “ MINT” countries, by stating that aggressive pricing controls and dominance of generic drugs, means ... Whilst the private sector represents

  • Exploring MINT: Part 4 - Turkey

    Why Turkey? With a population of approximately 75 million, Turkey has the smallest population of all of the ‘ MINT’ markets. ... As a result the greatest opportunities for pharma, within the MINT markets, at this stage often lie within the private

  • Exploring MINT: Part 3 - Nigeria

    From a healthcare perspective, Nigeria has some parallels with the other MINT markets of Mexico and Indonesia. ... Given the infrastructural, political and fiscal challenges, Nigeria’ s potential may also take longer to realise, relative to the other

More from PMHub
Approximately 2 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics